Table 2.
Patient characteristics.
| Characteristic | Non-AF | AF | p Value |
|---|---|---|---|
| Age | 47.8 ± 19.2 | 58.8 ± 11.7 | 0.047 |
| Gender (%male) | 70% | 61% | 0.568 |
| Hypertension | 59% | 39% | 0.251 |
| Diabetes | 29% | 28% | 0.917 |
| CAD | 41% | 33% | 0.643 |
| Family history of heart disease | 65% | 44% | 0.409 |
| ACEI Therapy | 53% | 44% | 0.627 |
| AT1RB Therapy | 29% | 17% | 0.384 |
| Ca++ blocker therapy | 0% | 11% | 0.166 |
| Beta blocker therapy | 76% | 55% | 0.203 |
| SBP (mmHg) | 107.1 ± 18.3 | 120.8 ± 13.9 | 0.033 |
| DBP (mmHg) | 66.6 ± 12.2 | 73.8 ± 8.3 | 0.074 |
| Ejection fraction (% by ECHO) | 20.82 ± 2.3 | 22.67 ± 2.5 | 0.586 |
| TC (mg/dL) | 158.6 ± 33.6 | 158.0 ± 44.1 | 0.967 |
| TG (mg/dL) | 137.8 ± 57.2 | 144.5 ± 53.6 | 0.266 |
CAD, coronary artery disease; ACEI, angiotensin converting enzyme inhibitor; AT1RB, angiotensin II type-1 (AT1) receptor blocker; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides.